Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Avacta Group (AVCT) Share News

12345678910

Avacta says salivary gland cancer drug shrinks tumour

17th Dec 2025 12:30

(Alliance News) - Avacta Group PLC on Wednesday said new data demonstrated that its drug caused "robust and meaningful" tumour shrinkage in patients with salivary gland cancer. Read More

IN BRIEF: Avacta to announce initial phase 1b data on faridoxorubicin

8th Dec 2025 11:41

Avacta Group PLC - Wetherby, West Yorkshire-based life sciences company - Expects to announce initial faridoxorubicin phase 1b data in the salivary gland cancer indication next week Wednesday. Back in October, Avacta had said faridoxorubicin showed positive tolerability and safety in patents across both the every three weeks and every two weeks dosing regiments. Faridoxorubicin is a form of doxorubicin designed to reduce the systemic side effects of conventional chemotherapy and concentrate the active payload in the tumour microenvironment. Doxorubicin is a chemotherapy drug used to treat cancer. Read More

Avacta hails data for faridoxorubicin to treat salivary gland cancers

20th Oct 2025 12:30

(Alliance News) - Avacta Group PLC on Monday said its lead programme faridoxorubicin showed favourable safety and tolerability in patients with salivary gland cancers. Read More

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

30th Sep 2025 13:11

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

23rd Sep 2025 13:48

Read More

CORRECT (Sep 01): hVIVO appoints Avacta Chair Shaun Chilton to board

22nd Sep 2025 18:09

(Correcting share price for September 1.) Read More

IN BRIEF: Avacta completes GBP2 million Coris Bioconcept sale

1st Sep 2025 17:03

Avacta Group PLC - Wetherby, West Yorkshire-based life sciences company - Completes sale of Coris Bioconcept SRL to 3B BlackBio Dx Ltd on Friday. Says all closing conditions for the takeover have been satisfied. Company previously announced the sale in late July, with Bhopal, India-based 3B BlackBio to pay GBP2.2 million up front. Deal includes an additional earn-out worth up to GBP615,000 based on future performance. Coris Bioconcept specialises in developing, manufacturing and marketing rapid diagnostic tests. Read More

hVIVO appoints Avacta Chair Shaun Chilton to lead board

1st Sep 2025 14:23

(Alliance News) - hVIVO PLC on Monday said it has appointed Shaun Chilton to the board of directors as non-executive chair with immediate effect. Read More

LONDON MARKET MIDDAY: Bank windfall tax fears weighs on FTSE 100

29th Aug 2025 12:09

(Alliance News) - Stock prices in Europe were lower at midday on Friday, in nervy trade before US data, while chatter about a windfall tax weighed on banking shares in London. Read More

AIM WINNERS & LOSERS: Avacta raises funds to make bond payment

29th Aug 2025 11:16

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More

Avacta Group sells Coris to transition to therapeutics business

28th Jul 2025 11:38

(Alliance News) - Avacta Group PLC shares climbed on Monday, after it agreed to sell Coris Bioconcept SRL to 3B BlackBio Dx Ltd for GBP2.2 million upfront. Read More

TRADING UPDATES: IntelliAM wins order; Schroder BSC mulls options

2nd Jul 2025 20:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

EXECUTIVE CHANGES: Avacta names CMO, Mission Group appoints CEO

1st Jul 2025 21:59

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

25th Jun 2025 14:21

Read More

TRADING UPDATES: Journeo in New York deal; Anpario to meet market view

19th Jun 2025 10:27

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

28th May 2025 15:02

Read More

Avacta sells Launch Diagnostics; reports "promising" efficacy data

7th Mar 2025 12:42

(Alliance News) - Avacta Group PLC on Friday said it has agreed to sell its UK-based and largest diagnostics unit, Launch Diagnostics Holdings Ltd, and reported "promising" early efficacy data in the treatment of salivary gland cancers. Read More

AIM WINNERS & LOSERS: Avacta makes progress on AVA6000 testing

7th Mar 2025 10:28

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More

EXECUTIVE CHANGES: Various Eateries hires Young's executive as CEO

13th Jan 2025 14:59

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and last week and not separately reported by Alliance News: Read More

LONDON BROKER RATINGS: RBC raises Hikma; JPMorgan cuts Schroders

10th Dec 2024 10:01

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

12345678910
FTSE 100 Latest
Value9,870.68
Change-18.54